Xiangming Ding

2.2k total citations · 1 hit paper
35 papers, 1.5k citations indexed

About

Xiangming Ding is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiangming Ding has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Xiangming Ding's work include MicroRNA in disease regulation (4 papers), Cancer-related gene regulation (4 papers) and RNA modifications and cancer (4 papers). Xiangming Ding is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related gene regulation (4 papers) and RNA modifications and cancer (4 papers). Xiangming Ding collaborates with scholars based in China, United States and Canada. Xiangming Ding's co-authors include Ming Liu, Burton B. Yang, Jian Shen, Qian Wang, Laurie K. McCauley, Cun-Yu Wang, Serk In Park, Jiong Li, Cun‐Yu Wang and Dean Tian and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular and Cellular Biology.

In The Last Decade

Xiangming Ding

34 papers receiving 1.5k citations

Hit Papers

Circbank: a comprehensive database for circRNA with stand... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangming Ding China 19 1.2k 636 181 118 112 35 1.5k
Pai‐Sheng Chen Taiwan 16 1.4k 1.2× 783 1.2× 244 1.3× 121 1.0× 100 0.9× 37 1.8k
José F. Ruiz Spain 17 1.0k 0.9× 377 0.6× 171 0.9× 158 1.3× 100 0.9× 29 1.4k
Zailong Qin China 20 754 0.6× 424 0.7× 270 1.5× 119 1.0× 83 0.7× 77 1.3k
Yuanzhong Wu China 21 1.3k 1.1× 544 0.9× 262 1.4× 52 0.4× 102 0.9× 50 1.6k
Xincheng Lu China 16 1.2k 1.0× 624 1.0× 357 2.0× 95 0.8× 72 0.6× 30 1.6k
Fang Zhao China 18 762 0.7× 365 0.6× 217 1.2× 178 1.5× 223 2.0× 44 1.4k
Peng Yao United States 23 1.4k 1.2× 484 0.8× 169 0.9× 105 0.9× 49 0.4× 56 1.9k
Sohee Jun United States 21 1.4k 1.2× 322 0.5× 412 2.3× 152 1.3× 168 1.5× 28 2.0k
Uri Nir Israel 21 860 0.7× 288 0.5× 182 1.0× 181 1.5× 113 1.0× 56 1.3k
Claudia Mertens United States 15 1.3k 1.1× 391 0.6× 328 1.8× 83 0.7× 144 1.3× 18 1.6k

Countries citing papers authored by Xiangming Ding

Since Specialization
Citations

This map shows the geographic impact of Xiangming Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangming Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangming Ding more than expected).

Fields of papers citing papers by Xiangming Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangming Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangming Ding. The network helps show where Xiangming Ding may publish in the future.

Co-authorship network of co-authors of Xiangming Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangming Ding. A scholar is included among the top collaborators of Xiangming Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangming Ding. Xiangming Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Yajun, et al.. (2024). Preoperative prediction for early recurrence of hepatocellular carcinoma using machine learning-based radiomics. Frontiers in Oncology. 14. 1346124–1346124. 1 indexed citations
2.
Xie, Meng, et al.. (2024). Vessel co-option: a unique vascular-immune niche in liver cancer. Frontiers in Oncology. 14. 1386772–1386772. 5 indexed citations
3.
Xu, Yuanpeng, et al.. (2024). A novel basement membrane-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma. Frontiers in Oncology. 14. 1388016–1388016. 1 indexed citations
5.
Ding, Xiangming, et al.. (2023). Risk prediction of second primary malignancies in primary colorectal neuroendocrine neoplasms patients: a population-based study. Journal of Endocrinological Investigation. 46(9). 1881–1889.
6.
Ding, Xiangming, et al.. (2022). Preoperative Oral Carbohydrate Levels in Patients with Type 2 Diabetes Mellitus: The Clinical Guiding Significance of Free Fatty Acids. Frontiers in Surgery. 9. 814540–814540. 3 indexed citations
7.
Zhang, Jiaqi, Kui Li, Xiangming Ding, et al.. (2021). Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients. Frontiers in Immunology. 12. 716075–716075. 16 indexed citations
8.
Li, Dongxiao, Xiangming Ding, Meng Xie, Dean Tian, & Limin Xia. (2021). COVID-19-associated liver injury: from bedside to bench. Journal of Gastroenterology. 56(3). 218–230. 41 indexed citations
10.
Li, Dongxiao, et al.. (2020). CAMSAP2-mediated noncentrosomal microtubule acetylation drives hepatocellular carcinoma metastasis. Theranostics. 10(8). 3749–3766. 22 indexed citations
11.
Han, Ping, Dongxiao Li, Lei Yu, et al.. (2019). A Potential Model for Detecting Crowding-induced Epithelial Cell and Cancer Cell Extrusion. Current Medical Science. 39(3). 391–395. 4 indexed citations
12.
He, Qin, Yu Fu, Xiangming Ding, et al.. (2018). High-mobility group box 1 induces endoplasmic reticulum stress and activates hepatic stellate cells. Laboratory Investigation. 98(9). 1200–1210. 29 indexed citations
13.
Aminzadeh, M, Russell G. Rogers, Mario Fournier, et al.. (2018). Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy. Stem Cell Reports. 10(3). 942–955. 96 indexed citations
14.
Li, Jiong, Bo Yu, Peng Deng, et al.. (2017). KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling. Nature Communications. 8(1). 15146–15146. 104 indexed citations
15.
Gong, Jin, Jian Han, Jiayi He, et al.. (2017). Paired related homeobox protein 1 regulates PDGF-induced chemotaxis of hepatic stellate cells in liver fibrosis. Laboratory Investigation. 97(9). 1020–1032. 19 indexed citations
16.
Li, Jiong, Xiaohong Chen, Xiangming Ding, et al.. (2013). LATS2 Suppresses Oncogenic Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction. Cell Reports. 5(6). 1650–1663. 63 indexed citations
17.
Ding, Xiangming. (2013). MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT). Chinese Journal of Cancer. 33(3). 140–147. 79 indexed citations
18.
Ding, Xiangming, Hongya Pan, Jiong Li, et al.. (2013). Epigenetic Activation of AP1 Promotes Squamous Cell Carcinoma Metastasis. Science Signaling. 6(273). ra28.1–13, S0. 97 indexed citations
19.
Ding, Xiangming, Serk In Park, Laurie K. McCauley, & Cun-Yu Wang. (2013). Signaling between Transforming Growth Factor β (TGF-β) and Transcription Factor SNAI2 Represses Expression of MicroRNA miR-203 to Promote Epithelial-Mesenchymal Transition and Tumor Metastasis. Journal of Biological Chemistry. 288(15). 10241–10253. 137 indexed citations
20.
Ding, Xiangming, et al.. (2007). SEPT12 Interacts with SEPT6 and This Interaction Alters the Filament Structure of SEPT6 in Hela Cells. BMB Reports. 40(6). 973–978. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026